Eligibility criteria
tumor, cognitive impairment, epilepsy, toxicity, stroke, psychiatric illness, intellectual disability, liver or renal failure, substance abuse, cardiac arrest, neurocognitive disorder, encephalopathy, infection, psychiatric, sepsis, cognitive complaints, hearing or vision disorders, head trauma
TUMOR, EPILEPSY, DRUG WITHDRAWAL, NEUROLOGICAL DISORDER, STROKE, MINOR, CARDIAC ARREST, DISORDERS, ENCEPHALOPATHY, INFECTION, SEPSIS
All volunteers will be screened by a psychologist. To be included in the study, participants must meet the following criteria: be able to understand the information and consent forms; aged 18 to 70 years; medically stable and at least 3 months after a positive COVID 19 infection confirmed either by PCR, self-test or medical advice; report sufficiently good physical condition to attend the appointments; report no major hearing or vision disorders; report cognitive complaints (that place the person in the top 20% of dissatisfied functioning on the BRIEF or MMQ questionnaires); poor but not necessarily deficient objective performance (supported by a score below the 20th percentile on one task of the cognitive battery). Participants will be excluded if they have any chronic or remote neurological disorder (i.e. stroke, head trauma, epilepsy, tumor); preexisting cognitive impairment (associated with another minor or major neurocognitive disorder; intellectual disability); acute brain injury or acute encephalopathy from another etiology than covid (e.g., sepsis, liver or renal failure, alcohol or drug withdrawal, drug toxicity); documented preexisting history of psychiatric illness (including substance abuse); open-heart cardiac surgery or cardiac arrest during the last 6 months; current hospitalization; current revalidation care with cognitive treatment. Participants with preexisting neurological, cognitive, or psychiatric disorders (i.e., preceding COVID) are also excluded. Individuals with disorders co-occurring with COVID are not excluded.